Sciton Halo: The new hybrid laser
The Sciton Halo hybrid fractional laser [Sciton] strikes a balance between nonablative and ablative results, according to Christopher Robb, M.D., Ph.D., a Nashville, Tenn., dermatologist, who conducted the initial patient protocol studies on the Halo.
“It’s a second-generation nonablative laser. It combines a new wavelength, 1470 nm nonablative, with an ablative erbium YAG 2940 nm [wavelength],” Dr. Robb says. “So, it’s combining two different treatments that in the past were done separately.”
This first-of-its-kind technology delivers nonablative and ablative pulses simultaneously. The 1470 nm wavelength delivers between 100 and 700 microns of coagulation to the epidermis and dermis. The 2940 nm wavelength delivers zero to 100 microns of ablation to the epidermis, according to a Sciton press release.
“With the older nonablative lasers, it would take seven or eight treatments to get results, but the downtime is really low, so people didn’t like coming back so often but were willing to do so because of the low downtime. Or they could do an ablative laser, which has a longer downtime,” Dr. Robb says. “This has found a balance. You can dial it in, so you can get an ablative result, but you have a nonablative healing time.”
The Halo is used to treat dyschromia, pores, wrinkles around the eyes and deep wrinkles. While best results are on the face, neck and chest, Dr. Robb says, it can be used to treat the hands and arms, too.
“It’s amazing for poikiloderma on the neck,” he says.
NEXT: Patient Selection & Cost